Company Profile For Sequenom Inc

Sequenom, Inc. (Sequenom) is a diagnostic testing and genetics analysis company. The Company is focused on providing products, services, diagnostic testing, applications and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock and other areas of research. Its development and commercialization efforts in various diagnostic areas include non-invasive prenatal diagnostics, oncology, infectious diseases and other disorders. The Company is researching, developing and pursuing the commercialization of various non-invasive molecular diagnostic tests for prenatal genetic disorders and diseases, oncology, infectious diseases, and other diseases and disorders. On November 14, 2008, it completed the asset acquisition of the Center for Molecular Medicine, LLC (CMM). On November 17, 2008, the Company acquired Grand Rapids, a center for molecular medicine.

BRIEF: For the six months ended 30 June 2009 Sequenom, Inc.'s revenues decreased 24% to $17.9M. Net loss totaled $37.7M, up from $18.4M. Revenues reflect lower sales from system related products, deceased services income and lower research & other income. Net loss also reflects an increase in research & development expenses, higher selling & marketing expenses, a rise in general & administrative expenses and the presence of restructuring charges.